Testosterone Gel, 1%

FDA Drug Profile — Testosterone Gel, 1%

Testosterone Gel, 1% is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Testosterone Gel, 1%. Available dosage form: gel.

Drug details

Generic Name
Testosterone Gel, 1%
Brand Names
Testosterone Gel, 1%
Application Number
ANDA212984
Sponsor
Encube Ethicals, Inc.
NDC Codes
2
Dosage Forms
GEL
Routes
TRANSDERMAL
Active Ingredients
TESTOSTERONE

Indications and Usage

1 INDICATIONS AND USAGE Testosterone gel, 1% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations, but have gonadotropins in the normal or low range. Limitations of use: Safety and efficacy of testosterone gel, 1% in men with "age-related hypogonadism" (also referred to as "late-onset hypogonadism") have not been established. Safety and efficacy of testosterone gel, 1% in males less than 18 years old have not been established [ see Use in Specific Populations ( 8.4 ) ]. Topical testosterone products may have different doses, strengths or application instructions that may result in different systemic exposure ( 1 , 12.3 ). Testosterone gel, 1% is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired). ( 1 ) Hypogonadotropic hypogonadism (congenital or acquired). ( 1 ) Limitations of use: Safety and efficacy of testosterone gel, 1% in men with “age-related hypogonadism” have not been established. ( 1 ) Safety and efficacy of testosterone gel, 1% in males less than 18 years old have not been established. ( 8.4 ) Topical testosterone products may have different doses, strengths or application instructions that may result in different systemic exposure. ( 1 , 12.3 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.